A double-blind, randomized trial of pyridoxine versus placebo for the prevention of pegylated liposomal doxorubicin-related hand-foot syndrome in gynecologic oncology patients

Cancer
Vivian von GruenigenSteven Waggoner

Abstract

The objective of this study was to compare the incidence of hand-foot syndrome (HFS) in patients who received pyridoxine versus placebo during pegylated liposomal doxorubicin (PLD) chemotherapy for recurrent ovarian, breast, or endometrial cancer. Patients received PLD 40 mg/m(2) for a maximum of 6 cycles. Patients were assigned randomly to receive pyridoxine 100 mg twice daily (Group A) or placebo (Group B) and received standard HFS education. Patients completed the Functional Assessment of Cancer Therapy quality-of-life (QOL) questionnaire. The incidence of HFS as measured by common toxicity criteria was compared between groups. Analyses were conducted according to an intent-to-treat basis. Chi-square tests or Fisher exact tests were used. Thirty-four patients were enrolled (18 in Group A and 16 in Group B), and 5 patients were unevaluable for HFS assessment. Overall, 15 of 29 patients (52%) had HFS (all grades), and 10 of 29 patients (35%) had grade 2/3 events. Eight of 15 patients in Group A (53%) and 7 of 14 patients in Group B (50%) had HFS (P = .857). For grade 2/3 events, there was no difference between groups: Six of 15 events (40%) occurred in Group A, and 4 of 14 events (29%) occurred in Group B (P = .70). There was ...Continue Reading

References

Jul 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J KavanaghA Kudelka
Mar 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D F CellaJ Brannon
May 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S ChiaraR Rosso
Mar 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K Basen-EngquistD M Gershenson
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A N GordonA J Lacave
Jul 13, 2002·Expert Review of Anticancer Therapy·T Tejada-BergesW Gajewski
Feb 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Beth Overmoyer
Sep 25, 2003·Journal of Cancer Research and Clinical Oncology·Pedro F EscobarJerome Belinson
Apr 27, 2005·Evaluation & the Health Professions·Penny S BruckerDavid Cella
Aug 20, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lari WenzelDavid Cella
Mar 8, 2006·The Canadian Journal of Cardiology·Joan IvanovTirone E David
Apr 21, 2006·The American Journal of Dermatopathology·Francois M CadyJohn S Metcalf
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael A Bookman
Jul 23, 2008·Archives of Dermatology·Julien AutierCaroline Robert
Aug 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nilofer S AzadElise C Kohn
Dec 17, 2008·Cancer Control : Journal of the Moffitt Cancer Center·Christina B MarquezBasil S Cherpelis
Feb 21, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Nilofer S AzadHeidi H Kong
May 18, 2010·Journal of Pain and Symptom Management·Vivian E von GruenigenLari Wenzel

❮ Previous
Next ❯

Citations

Jan 28, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lígia Traldi MacedoAndre Deeke Sasse
May 6, 2014·Journal of the American Academy of Dermatology·Kristen K MillerBeth N McLellan
Jun 9, 2014·Cancer Chemotherapy and Pharmacology·Bingnan ZhangNikolai Podoltsev
Sep 30, 2014·Molecular Pharmaceutics·Jianqin LuSong Li
May 11, 2012·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Lisa ZimmerDirk Schadendorf
Jul 20, 2014·Journal of the American Academy of Dermatology·Claire Marie Reyes-Habito, Ellen K Roh
Aug 12, 2014·Journal of Traditional Chinese Medicine = Chung I Tsa Chih Ying Wen Pan·Changlin ZhaoXiaoyin Chen
Feb 11, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Naoko MikoshibaMitsunori Miyashita
Mar 25, 2014·The Breast : Official Journal of the European Society of Mastology·Arnoud J TempletonUNKNOWN Swiss Group for Clinical Cancer Research (SAKK) Coordinating Center
May 26, 2016·American Journal of Clinical Dermatology·Kumutnart ChanprapaphVasanop Vachiramon
May 19, 2020·American Society of Clinical Oncology Educational Book·Alana DeutschBeth N McLellan
May 15, 2020·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Kazuteru WatanabeItaru Endo
Jun 28, 2020·European Journal of Hospital Pharmacy. Science and Practice·Yao ZhuXiaoling Zheng
Jan 8, 2020·International Journal of Women's Dermatology·Michelle N FerreiraJonathan S Leventhal
Nov 16, 2020·Clinical and Experimental Dermatology·S LianQ Zhao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Roger von MoosAxel Hauschild
© 2021 Meta ULC. All rights reserved